282 related articles for article (PubMed ID: 27060910)
1. Italian expert consensus for the management of actinic keratosis in immunocompetent patients.
Peris K; Calzavara-Pinton PG; Neri L; Girolomoni G; Malara G; Parodi A; Piaserico S; Rossi R; Pellacani G
J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1077-84. PubMed ID: 27060910
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy of actinic keratosis: an update.
Berman B; Amini S
Expert Opin Pharmacother; 2012 Sep; 13(13):1847-71. PubMed ID: 22888917
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy of actinic keratosis.
Berman B; Amini S; Valins W; Block S
Expert Opin Pharmacother; 2009 Dec; 10(18):3015-31. PubMed ID: 19925043
[TBL] [Abstract][Full Text] [Related]
4. Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
Philipp-Dormston WG
Curr Probl Dermatol; 2015; 46():115-21. PubMed ID: 25561215
[TBL] [Abstract][Full Text] [Related]
5. A cost-utility analysis of ingenol mebutate gel for the treatment of actinic keratosis: a Scottish perspective.
Tolley K; Kemmett D; Thybo S; Nasr R; Smethurst H
Eur J Health Econ; 2016 Apr; 17(3):287-304. PubMed ID: 25795391
[TBL] [Abstract][Full Text] [Related]
6. The importance of treating the field in actinic keratosis.
Stockfleth E
J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():8-11. PubMed ID: 28263021
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis.
Stockfleth E; Bastian M
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):911-918. PubMed ID: 30074409
[TBL] [Abstract][Full Text] [Related]
8. Field Cancerization Therapies for Management of Actinic Keratosis: A Narrative Review.
Jetter N; Chandan N; Wang S; Tsoukas M
Am J Clin Dermatol; 2018 Aug; 19(4):543-557. PubMed ID: 29582369
[TBL] [Abstract][Full Text] [Related]
9. Field Cancerization Therapies for the Management of Actinic Keratosis: An Updated Review.
Aggarwal I; Puyana C; Chandan N; Jetter N; Tsoukas M
Am J Clin Dermatol; 2024 May; 25(3):391-405. PubMed ID: 38351246
[TBL] [Abstract][Full Text] [Related]
10. Management of actinic keratosis: a practical report and treatment algorithm from AKTeam™ expert clinicians.
Dréno B; Amici JM; Basset-Seguin N; Cribier B; Claudel JP; Richard MA;
J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1141-9. PubMed ID: 24612407
[TBL] [Abstract][Full Text] [Related]
11. Physicians' opinions and clinical practice patterns for actinic keratosis management in Italy.
Peris K; Neri L; Calzavara Pinton P; Catricalà C; Pellacani G; Pimpinelli N; Peserico A
G Ital Dermatol Venereol; 2014 Apr; 149(2):185-92. PubMed ID: 24819638
[TBL] [Abstract][Full Text] [Related]
12. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 2: Commonly used field-directed and lesion-directed therapies.
Berman B; Cohen DE; Amini S
Cutis; 2012 Jun; 89(6):294-301. PubMed ID: 22838095
[TBL] [Abstract][Full Text] [Related]
13. Current therapies for actinic keratosis.
Dianzani C; Conforti C; Giuffrida R; Corneli P; di Meo N; Farinazzo E; Moret A; Magaton Rizzi G; Zalaudek I
Int J Dermatol; 2020 Jun; 59(6):677-684. PubMed ID: 32012240
[TBL] [Abstract][Full Text] [Related]
14. Actinic keratosis: where do we stand and where is the future going to take us?
Cramer P; Stockfleth E
Expert Opin Emerg Drugs; 2020 Mar; 25(1):49-58. PubMed ID: 32067498
[No Abstract] [Full Text] [Related]
15. [Not Available].
Herms F
Ann Dermatol Venereol; 2019 May; 146 Suppl 2():IIS22-IIS30. PubMed ID: 31133226
[TBL] [Abstract][Full Text] [Related]
16. The paradigm shift in treating actinic keratosis: a comprehensive strategy.
Stockfleth E
J Drugs Dermatol; 2012 Dec; 11(12):1462-7. PubMed ID: 23377517
[TBL] [Abstract][Full Text] [Related]
17. Topical management of actinic keratosis and field cancerisation.
Stockfleth E
G Ital Dermatol Venereol; 2009 Aug; 144(4):459-62. PubMed ID: 19755950
[TBL] [Abstract][Full Text] [Related]
18. Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.
Gutzmer R; Wiegand S; Kölbl O; Wermker K; Heppt M; Berking C
Dtsch Arztebl Int; 2019 Sep; 116(37):616-626. PubMed ID: 32048593
[TBL] [Abstract][Full Text] [Related]
19. Treatment considerations in actinic keratosis.
Goldenberg G
J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():12-16. PubMed ID: 28263018
[TBL] [Abstract][Full Text] [Related]
20. Management of actinic keratosis at specific body sites in patients at high risk of carcinoma lesions: expert consensus from the AKTeam™ of expert clinicians.
Richard MA; Amici JM; Basset-Seguin N; Claudel JP; Cribier B; Dreno B
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):339-346. PubMed ID: 29235161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
